RGD Reference Report - The renin-angiotensin system: peptides and enzymes beyond angiotensin II. - Rat Genome Database

Send us a Message
Submit Data |  Help |  Video Tutorials |  News |  Publications |  Download |  REST API |  Citing RGD |  Contact   
Search RGD Grant Resources Citing RGD About Us Contact Us
Genes Variants Community Projects QTLs Strains Markers Genome Information Ontologies Cell Lines References Download Submit Data
OntoMate (Literature Search) JBrowse (Genome Browser) Synteny Browser (VCMap) Variant Visualizer Multi-Ontology Enrichment (MOET) Gene-Ortholog Location Finder (GOLF) InterViewer (Protein-Protein Interactions) PhenoMiner (Quatitative Phenotypes) Gene Annotator OLGA (Gene List Generator) AllianceMine GViewer (Genome Viewer)
Aging & Age-Related Disease Cancer & Neoplastic Disease Cardiovascular Disease Coronavirus Disease Developmental Disease Diabetes Hematologic Disease Immune & Inflammatory Disease Infectious Disease Liver Disease Neurological Disease Obesity & Metabolic Syndrome Renal Disease Respiratory Disease Sensory Organ Disease
Find Models Genetic Models Autism Models Rat PhenoMiner (Quantitative Phenotypes) Chinchilla PhenoMiner Expected Ranges (Quantitative Phenotype) PhenoMiner Term Comparison Hybrid Rat Diversity Panel Phenotypes Phenotypes in Other Animal Models Animal Husbandry Strain Medical Records Phylogenetics Strain Availability Calendar Rats 101 Submissions Photo Archive
Pathways
Rat Community Forum Directory of Rat Laboratories Video Tutorials News RGD Publications RGD Presentations Archive Nomenclature Guidelines Resource Links Laboratory Resources Employment Resources
Advanced Search (OLGA)

The renin-angiotensin system: peptides and enzymes beyond angiotensin II.

Authors: Reudelhuber, TL 
Citation: Reudelhuber TL Curr Opin Nephrol Hypertens. 2005 Mar;14(2):155-9.
RGD ID: 1581849
Pubmed: PMID:15687842   (View Abstract at PubMed)

PURPOSE OF REVIEW: Although current pharmacotherapy for cardiovascular disease focuses on the inhibition of angiotensin II production and action, several other biologically active peptides are produced by the renin-angiotensin system. RECENT FINDINGS: Recent biochemical and physiological studies have shown that non-angiotensin II peptides, including angiotensins III, IV and 1-7, modulate blood pressure or cardiac function through novel mechanisms. Animal models support the notion that these peptides are physiologically important. SUMMARY: Although the role of these peptides has not yet resulted in the development of new therapies for the treatment of cardiovascular disease, they hold promise for identification of complimentary targets.



Molecular Pathway Annotations    Click to see Annotation Detail View

RGD Manual Annotations


  
Object SymbolSpeciesTermQualifierEvidenceWithNotesSourceOriginal Reference(s)
LNPEPHumanrenin-angiotensin cascade pathway   TAS  RGD 
LnpepRatrenin-angiotensin cascade pathway   TAS  RGD 
LnpepMouserenin-angiotensin cascade pathway   TAS  RGD 
MAS1Humanrenin-angiotensin cascade pathway   ISOMas1 (Mus musculus) RGD 
Mas1Ratrenin-angiotensin cascade pathway   TAS  RGD 
Mas1Mouserenin-angiotensin cascade pathway   TAS  RGD 
Objects Annotated

Genes (Rattus norvegicus)
Lnpep  (leucyl and cystinyl aminopeptidase)
Mas1  (MAS1 proto-oncogene, G protein-coupled receptor)

Genes (Mus musculus)
Lnpep  (leucyl/cystinyl aminopeptidase)
Mas1  (MAS1 oncogene)

Genes (Homo sapiens)
LNPEP  (leucyl and cystinyl aminopeptidase)
MAS1  (MAS1 proto-oncogene, G protein-coupled receptor)


Additional Information